Cavelier

The ‘highly specialised, dynamic, and efficient’ practice at Cavelier advises life sciences clients across the full suite of regulatory compliance, IP portfolio management, data protection and litigation. Notably, its contentious work took centre stage during 2024/25, when the team was engaged to represent ViiV Healthcare, GSK and Shionogi & Co in administrative and judicial proceedings stemming from the Ministry of Health’s decision to grant a compulsory licence for antiretroviral drug Dolutegravir. Department head Andrés Rincón leads the Dolutegravir litigation and is highlighted for his ’extensive knowledge, leadership and client commitment’. The group further draws on a strong second line of associates including senior Carolina Vargas, who specialises in patent work; and senior Eliana Portilla, who serves as associate co-ordinator of the patents area.